Semaglutide is a medication that has been approved by the FDA for use in the treatment of obesity. The drug is a GLP-1 receptor agonist, which means that…
Read More
Due to its all-natural, non-invasive method of regenerating skin and encouraging hair development, platelet-rich plasma (PRP) therapy has grown in popularity in recent years. A small amount of a patient’s…
EMSELLA - Amazing New Technology for Urinary Incontinence. Click to read this transcript Emsella's Benefits for Men and Women in Treating Urinary Incontinence and Improving Sexual Stimulation Sexual dysfunction and...
Read More
EMSCULPT NEO exclusive provider in Greater Cincinnati, Emsculpt NEO is the latest nonsurgical treatment to reduce unwanted FAT up to 30% and gain and build muscle to 25%. Click...
Read More
Kiss & Tell and Save $75 on Lip Fillers - Get Kissable Lips for Valentine's Day! They say don't Kiss & Tell, but we disagree! Save $75 on Lip...
Read More
EM EVENT Join us on Wednesday, February 15, 2023 from 4-6:30pm for live demonstrations of EMFACE, EMSCULPT NEO and EMSELLA! Say goodbye to stubborn fat and hello to...
Read More
Facelift Recovery: Zamaris details her day-to-day face lift progress Zamaris had the Advanced Facelift Patient and Upper Eyelid Blepharoplasty procedure by Dr. Jon Mendelsohn Here she details day to day...
Read More
Jeaneen shares her Day-by-Day Recovery from Upper Blepharoplasty Surgery by Dr. Jon Mendelsohn Jeaneen shares her Day-by-Day Recovery from Upper Blepharoplasty Surgery by Dr. Jon Mendelsohn. Her actual surgery and...
Read More
LIVE UPPER EYELID PROCEDURE (BLEPHAROPLASTY) BY DR. MENDELSOHN Okay, So there's really not much bleeding, but we're going to use an instrument called the cautery, bipolar cautery, to just seal...
Read More
Liz Bonis with WKRC-TV – Watch a Live EMFACE Demonstration – Less Wrinkles! More Lift! Non-Surgical!
Look Good on Your Lunch Hour with the newest non-surgical procedure for the Face! Click to read this transcript Dr. Jon Mendelsohn is proud to offer this revolutionary facial...
Read More
Recent Comments